What's Happening?
10x Genomics has unveiled its new spatial instrument, the Atera, at the American Association for Cancer Research (AACR) conference in San Diego. The Atera platform offers enhanced capabilities for whole-transcriptome spatial biology, providing higher
throughput, plex capacity, and sensitivity compared to previous tools. CEO Serge Saxonov highlighted the platform's potential to transform biological measurement and research. The Atera is priced at $495,000 and is expected to be available later this year. It supports extensive sample processing and customization, making it a significant advancement in spatial genomics.
Why It's Important?
The launch of the Atera platform represents a major advancement in spatial genomics, a field crucial for understanding complex biological systems. By enabling detailed spatial analysis of gene expression, the platform can enhance research in areas such as cancer biology, potentially leading to new insights and therapeutic strategies. The increased capabilities of Atera could accelerate research and development in genomics, impacting fields ranging from basic science to clinical applications. This innovation underscores the growing importance of spatial biology in advancing personalized medicine and understanding disease mechanisms.
What's Next?
10x Genomics plans to continue developing the Atera platform, with future enhancements in spatial proteomics, automation, and sequencing. The platform is expected to play a key role in large-scale projects like the Human Cell Atlas, which aims to map every cell type in the human body. As the platform becomes available, researchers will likely explore its applications in various fields, potentially leading to new discoveries and innovations in genomics and related disciplines.
